Abundance: Viruses infect all types of cells (bacteria, algae, fungi, protozoa, plants, animals).
Active and inactive states: Viral activity is categorized as active (capable of infection) or inactive (unable to infect) instead of alive or dead.
Obligate intracellular parasites: Require host cells for reproduction.
Virion: The complete, infective form of a virus outside of a host cell.
Influence genetic makeup: Viruses shape the evolution of cells, tissues, and organisms.
Human genome: 40% to 80% may consist of remnants from ancient viral infections.
Part of microbiome: Viruses are components of the normal microbiome.
Smaller than bacteria: Examples range from Parvoviruses (~0.02 μm) to Pandoravirus (similar in size to some bacteria).
Visualization: Requires electron microscopy for observation.
Basic components: Includes genetic material (DNA or RNA), a protective capsid, and sometimes an outer lipid envelope.
Capsid: A protein coat surrounding the genetic material.
Envelope: Derived from the host cell membrane for protection and infection assistance.
Glycoproteins (spikes): Essential for attachment to host cells.
Shapes of viral capsids: (a) Helical, (b) Polyhedral, (c) Complex.
Capsid: The protein shell encasing the viral genome, made of capsomeres.
Nucleocapsid: The combination of the viral genome and capsid.
Envelope: Lipid membrane from the host cell, found in some viruses.
Spikes: Protruding structures for host cell attachment.
Found in bacteriophages that infect bacteria.
Non-symmetrical shapes and multi-protein types.
Example: T4 bacteriophage has a complex capsid with a tail.
Composed of rod-shaped capsomeres in a continuous helical structure.
Naked helical viruses: Rigid nucleocapsid example - Tobacco mosaic virus.
Enveloped helical viruses: Flexible nucleocapsid (examples: Influenza, measles, rabies virus).
Three-dimensional, 20-sided structures with symmetrical capsomeres.
Naked viruses (e.g., adenoviruses) lack an envelope; enveloped viruses (e.g., hepatitis B) possess one.
Can be DNA or RNA; not both.
Viral genes: Limited to those essential for host invasion and activity redirection (e.g., Hepatitis B has four genes).
Classified by nucleic acid type and replication strategy (Baltimore classification):
Class I: dsDNA (e.g., Herpes simplex virus).
Class II: ssDNA (e.g., Parvovirus B19).
Class III: dsRNA (e.g., Rotavirus).
Class IV: (+)ssRNA (e.g., Poliovirus).
Class V: (-)ssRNA (e.g., Influenza).
Class VI: ssRNA-RT (e.g., HIV).
Class VII: dsDNA-RT (e.g., Hepatitis B).
Adsorption: Virus attaches to host cell receptors.
Penetration: Virus enters via fusion or endocytosis.
Uncoating: Removal of viral capsid releasing genome.
Synthesis: Host machinery produces viral components.
Assembly: New viral particles are formed.
Release: New viruses exit via budding (enveloped) or lysis (naked).
Virus encounters and attaches to the host cell's receptor sites.
Host range: Compatibility of viral proteins with host cell receptors.
Restricted: Hepatitis B (liver cells only).
Moderate: Poliovirus (intestinal and nerve cells).
Broad: Rabies virus (various mammalian cells).
Endocytosis: Virus is engulfed by the cell.
Uncoating: Enzymes dissolve the envelope/capsid releasing the virus into the cytoplasm.
DNA viruses replicate in the nucleus; RNA viruses in cytoplasm.
Retroviruses (e.g., HIV) reverse transcribe RNA to DNA and integrate into the host genome.
Enveloped viruses: Released by budding; do not destroy the host cell.
(+)ssRNA can be directly read by ribosomes; (-)ssRNA requires synthesis of (+)ssRNA for protein production.
Specific mechanisms for RNA versus DNA replication cycles.
Common and serious diseases caused by viruses: colds, influenza, chickenpox, herpes, etc.
High mortality viruses: Ebola, rabies.
Chronic conditions linked to viruses: HIV/AIDS, hepatitis.
Rapid mutation rates complicate effective long-term treatment development.
Limited antiviral drug options often targeting specific life cycle stages.
Vaccines are the best prevention but not available for all viral infections.
Targets for antiviral drug development:
Entry inhibitors: Block virus entry.
Reverse transcriptase inhibitors: Used in HIV treatment.
Protease inhibitors: Block viral protein processing.
Neuraminidase inhibitors: Prevent release of new particles.
Interferons: Antiviral properties from host immune system.
Non-living agents needing host cells to replicate.
Simple structure, diverse and significant roles in health and ecology.
Understanding viruses is crucial for developing treatments and preventing diseases.
Prions, while not viruses, pose similar health threats with distinct mechanisms.